| Batimastat (BB-94)MMP inhibitor |
Sample solution is provided at 25 µL, 10mM.
2. Zhang K, Liu X, Hao F, Dong A, Chen D. "Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling." Am J Transl Res. 2016 May 15;8(5):2196-209. PMID:27347327
Quality Control & MSDS
- View current batch:
Chemical structure
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
| Description | Batimastat (BB-94) is a potent, broad spectrum inhibitor of matrix metalloprotease (MMP) for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3 with IC50 of 3 nM, 4 nM, 4 nM, 6 nM and 20 nM, respectively. | |||||
| Targets | MMP-1 | MMP-2 | MMP-9 | MMP-7 | MMP-3 | |
| IC50 | 3 nM | 4 nM | 4 nM | 6 nM | 20 nM | |
| Cell experiment: | |
|
Cell lines |
C170HM2 and AP5LV cell lines |
|
Preparation method |
The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. |
|
Reaction Conditions |
96 h; 3.0 μg/ml |
|
Applications |
In vitro proliferation in the presence of batimastatwas assessed by the MTT absorbance assay. The effect of batimastat on the in vitro growth of C170HM2 and AP5LV in both serum-free and scrum-containing culture media was determined three times. Batimastat had no significant effect on the growth of either cell line. |
| Animal experiment: | |
|
Animal models |
Orthotopic transplant model of human colon cancer in nude mice |
|
Dosage form |
30 mg/kg; i.p. |
|
Applications |
Treatment with BB-94 caused a significant reduction in the median weight of the primary tumor from 293 mg(range, 1141 to 124 mg) in the control group to 144 mg (range, 424 to 38 mg) in the BB-94 treated group (P < 0.001) and resulted in a marked reduction in the incidence of tumor invasion of adjacent tissue, from 12 of 18 mice in the control group (67%) to 7 of 20 mice in the BB-94 treated group (35%). |
|
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
|
References: [1] Watson S A, Morris T M, Robinson G, et al. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models[J]. Cancer research, 1995, 55(16): 3629-3633. [2] Wang X, Fu X, Brown P D, et al. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice[J]. Cancer research, 1994, 54(17): 4726-4728. | |
Batimastat (BB-94) Dilution Calculator
Batimastat (BB-94) Molarity Calculator
| Cas No. | 130370-60-4 | SDF | Download SDF |
| Synonyms | Batimastat,BB-94 | ||
| Chemical Name | (2S,3R)-N1-hydroxy-3-isobutyl-N4-((S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl)-2-((thiophen-2-ylthio)methyl)succinamide | ||
| Canonical SMILES | CNC([C@@H](NC([C@@H]([C@H](CSC1=CC=CS1)C(NO)=O)CC(C)C)=O)CC2=CC=CC=C2)=O | ||
| Formula | C23H31N3O4S2 | M.Wt | 477.64 |
| Solubility | >23.9mg/mL in DMSO | Storage | Store at 4°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. | ||
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
||
Abstract
Batimastat was in complex with crystallized ADAM-8 protein.
Abstract
The treatment of batimastat, an inhibitor of MMPs, in mdx mice resulted in increased muscle force production in isometric contraction, augmented levels of sarcolemmal protein beta-dystroglycan and neuronal nitric oxide and reduced necrosis, infiltratiom of macrophages, centronucleated fibers, expression of embryonic myosin heavy chain in skeletal muscle and activation of mitogen-activated protein kinases and activator protein-1 in myofibers.
Abstract
Batimastat, a MMP-9 inhibitor, was investigated for protective effect in CPB-induced dog lung injury.
Abstract
Batimastat, a metalloproteinase inhibitor, inhibited lethality of low dose venom and concentration-dependently delayed death induced by high dose venom in mice, which also inhibited venom-induced in vitro coagulant, in vivo defibrinogenating and hemorrhagic effects.
Abstract
Batimastat, a MMP inhibitor, caused retardation of tumor growth with no regression in a human breast cancer xenograft model and significantly increased expression of uPA in tumors.
Batimastat (also known as BB-49), [4-(N-hydroxyamino)-2R-isobutyl-3S-(thiopen-2-ylthiomethyl)-succinyl-L-phenylalanine-N-methylamide, is a potent and synthetic inhibitor of a broad spectrum of matrix metalloproteinases (MMPs), including interstitial collagenase (IC50 = 3 nM), stromelysin (IC50 = 20 nM), Mr 72,000 type IV collagenase (IC50 = 4 nM), Mr 92,000 type IV collagenase (IC50 = 4 nM), and matrilysin (IC50 = 6 nM). It is a low-molecular-weight (MW = 478) and peptide-like collagen substrate analogue consisting of a peptide backbone and a hydroxamic acid group which bind to MMPs and the catalytically active zinc atom respectively. Batimastat exhibits antineoplastic and antiangiogenic activity in various tumor models, including ovarian carcinoma xegnografts and human colon tumor.
Reference
Bernard Davies, Peter D. Brown, Nick East, Michael J. Crimmin, and Frances R. Balkwill. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Research 1993; 53: 2087-2091
X. Wang, X. Fu, P.D. Brown, M. J. Crimmin, and R. M. Hoffman. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Research 1994; 54: 4726-4728
Raffaella Giavazzi, Angela Garofalo, Cristina Ferri, Valeria Lucchini, Elisabeth A. Bone, Stefania Chiari, Peter D. Brown, M. Ines Nicoletti, and Giulia Taraboletti. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xgenografts. Clinical Cancer Research 1998; 4: 985-992
